J9011 Datopotamab deruxtecan, 1 milligrams
J-Codes
Also known as: Dato-DXd, Datopotamab deruxtecan
Datopotamab deruxtecan administered by injection at 1 milligram per dose; an antibody-drug conjugate targeting tissue factor pathway inhibitor.
Clinical Context
Used for HER2-low breast cancer and other solid tumors. Antibody-drug conjugate delivering chemotherapy directly to cancer cells.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.